Glipizide
- Product NDC
- 60760-329
- 11-digit product format
- 607600329
- Labeler code
- 60760
- Product ID
- 60760-329_b404115d-71a2-9657-e053-2995a90ab23e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glipizide
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- St. Mary's Medical Park Pharmacy
- Application
- ANDA206928
- Marketing category
- ANDA
- Marketing start
- 2020-11-16
- Marketing end
- 0000-00-00
- Substance
- GLIPIZIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60760-329 | GLIPIZIDE TABLET, EXTENDED RELEASE [ST. MARY'S MEDICAL PARK PHARMACY] | 1 | Legacy NDC | 20201203_b404115d-71a1-9657-e053-2995a90ab23e.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60760-329-30 | 60760032930 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60760-329-30) | 2020-11-16 | 0000-00-00 | No | No | Current |